Lynx.MD transforms life science research with unparalleled access to rich, real-world data
Life science advancement depends on data to inform innovation. The Lynx.MD medical intelligence platform provides pharmaceutical and life sciences companies secure access to anonymized real-world patient data to accelerate the development of diagnostic and therapeutic solutions while ensuring compliance with GDPR and HIPAA regulations.
Research & development exploration
Rapid access to data for clinical trial design and fine tuning of selection of criteria and site selections.
Rich, diverse datasets
Access millions of previously inaccessible unstructured and structured datasets—X-rays, physicians’ notes, prescriptions, hospital records and more.
Build and model for comparative performance outcomes, HEOR and market segmentations.
The Lynx.MD medical intelligence platform unites the medical discovery ecosystem to scale healthcare innovation through secure access to real-world, anonymized patient data. Life science researchers and analysts gain access to patient records and longitudinal patient journey data to design clinical trials, test treatment effectiveness and drive decision-making.
Biotech use cases
Access to real world data, patient journeys, outcomes and notes
Examine market size and cost of standard treatments
Analyze how to price and position products
Pharma use cases
Design more cost-efficient clinical trials
Perform post-market validation of drugs
Investigate drug repurposing opportunities
Digital Health use cases
Access a wider breadth of medical knowledge
Monitor quality of care across the board
Facilitate and improve support and services
Payers use cases
Identify high-risk, high-cost patients
Support value-based contracting
Create a higher quality of service for patients